CERUBIDIN

This brand name is authorized in Ireland, Malta.

Active ingredients

The drug CERUBIDIN contains one active pharmaceutical ingredient (API):

1	Daunorubicin UNII UD984I04LZ - DAUNORUBICIN HYDROCHLORIDE
	Daunorubicin is an anthracycline glycoside antibiotic and is a potent antileukaemic agent. It also has immunosuppressant effects. Daunorubicin may involve binding to DNA by intercalation between base pairs and inhibition of DNA and RNA synthesis by template disordering and steric obstruction.
	Read more about Daunorubicin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CERUBIDIN Powder for concentrate for solution for infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01DB02	Daunorubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MT	Medicines Authority	AA565/68001